Corrigendum to "Psychedelic therapy for depressive symptoms: A systematic review and meta-analysis" [Journal of affective disorders, 322 (2023), 194-204].

J Affect Disord April 3, 2025 correction DOI: 10.1016/j.jad.2025.03.145 (opens in new tab)

Study at a glance

AI-extracted from the abstract

Characteristics	Corrigendum
Topics	Depression Psychedelic-assisted therapy

Abstract

Corrigendum to "Psychedelic therapy for depressive symptoms: A systematic review and meta-analysis" [Journal of affective disorders, 322 (2023), 194-204].

Corrigendum to "The role of the psychedelic experience in psilocybin treatment for treatment-resistant depression" [Journal of Affective Disorders, Volume 372 (2025), Pages 523-532]. J Affect Disord October 10, 2025
Corrigendum to “Psychedelic therapy for depressive symptoms: A systematic review and meta-analysis”. [J. Affect. Disord., 322 (2023), 194–204] Journal of Affective Disorders January 5, 2024 1 citation
Corrigendum to "Psychedelic Assisted Therapy as a Complex Intervention: Implications for clinical trial design". Therapeutic Advances in Psychopharmacology 2025
Corrigendum to 'Comment on: History repeating: guidelines to address common problems in psychedelic science'. Therapeutic Advances in Psychopharmacology 2024
Correction to: A Bayesian Reanalysis of a Trial of Psilocybin Versus Escitalopram for Depression by Nayak, et al. Psychedelic Med 2023;1(1):18–26; doi: 10.1089/psymed.2022.0002 Psychedelic Medicine May 3, 2024

Study at a glance

Abstract

Related reading